chr10-49610891-A-G
Variant summary
Our verdict is Uncertain significance. The variant received 2 ACMG points: 2P and 0B. PP3_Moderate
The NM_003055.3(SLC18A3):c.151A>G(p.Met51Val) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000372 in 1,613,024 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. M51I) has been classified as Uncertain significance.
Frequency
Consequence
NM_003055.3 missense
Scores
Clinical Significance
Conservation
Publications
- congenital myasthenic syndrome 6Inheritance: AR Classification: STRONG Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae), Genomics England PanelApp
- presynaptic congenital myasthenic syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 2 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152188Hom.: 0 Cov.: 34 show subpopulations
GnomAD4 exome AF: 0.00000342 AC: 5AN: 1460836Hom.: 0 Cov.: 79 AF XY: 0.00000275 AC XY: 2AN XY: 726658 show subpopulations
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152188Hom.: 0 Cov.: 34 AF XY: 0.0000135 AC XY: 1AN XY: 74336 show subpopulations
ClinVar
Submissions by phenotype
Congenital myasthenic syndrome 21 Uncertain:1
This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at